Anxiety, COVID, Depression, Postpartum
Conditions
Brief summary
In our study; Anxiety and depression levels, socio-demographic characteristics of the pregnant women who were admitted to our hospital between 25.04.2020-25.07.2020 and treated with the diagnosis of covid 19, and the change in anxiety and depression levelsWİTH Beck Depression and Anxiety Score after the disease regressed are planned. (Beck depression scale contains 10 questions and a total of 1 to 100 points is obtained. High score indicates that depression and anxiety are high.) 0-16 points = mild depressive symptoms 17-29 points = moderate depressive symptoms 30-63 points = severe depressive symptoms
Detailed description
The sociodemographic data form prepared by the researchers will be filled out by interviewing the patients who are willing to participate in the study. In addition, Beck Depression Scale, Beck Anxiety Scale, State and Trait Anxiety Scale will be given by the participants themselves. When the patients come to their first control after discharge, the scales specified will be repeated.
Interventions
BEHAVIORALcovid-19 positive pregnant women
It is planned to receive pregnant women who are admitted to the clinic or outpatient clinic and who are offered inpatient follow-up and treatment with the diagnosis of COVID-19. Pregnant women who do not have covid-19 disease as a control group and who do not have a comorbid disease at similar gestational week will be included in the study. As a control group, covid-19 pcr negative patients will be admitted to our clinic in the same period.
Sponsors
Ayşegül Bestel
İbrahim Polat
Merve Aldıkaçtıoğlu Talmaç
Kanuni Sultan Suleyman Training and Research Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
* covid -19 pcr positive pregnant women * no psychiatric diagnosis no use of psychiatric medicine
Exclusion criteria
Non-pregnant patients, A psychiatric diagnosis use of psychiatric medicine
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluation of depression and anxiety score changes of covid-19 positive pregnants | 4 months | Evaluation of depression and anxiety score changes of covid-19 positive pregnants Pregnant women are questioned how this period was affected, as the pandemic period loaded with extra stress and caused depression and anxiety. |
Countries
Turkey (Türkiye)
Outcome results
None listed